Indocin i.v. and Haematocrit decreased - a phase IV clinical study of FDA data
Haematocrit decreased is found among people who take Indocin i.v., especially for people who are male, 0-1 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Indocin i.v. and have Haematocrit decreased. It is created by eHealthMe based on reports of 459 people who have side effects when taking Indocin i.v. from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
459 people reported to have side effects when taking Indocin i.v..
Among them, 15 people (3.27%) have Haematocrit decreased.
What is Indocin i.v.?
Indocin i.v. has active ingredients of indomethacin sodium. eHealthMe is studying from 461 Indocin i.v. users for its effectiveness, alternative drugs and more.
What is Haematocrit decreased?
Haematocrit decreased is found to be associated with 2,869 drugs and 2,196 conditions by eHealthMe.
Number of Indocin i.v. and Haematocrit decreased reports submitted per year:
Time on Indocin i.v. when people have Haematocrit decreased *:
Gender of people who have Haematocrit decreased when taking Indocin i.v.*:
Age of people who have Haematocrit decreased when taking Indocin i.v. *:
Common drugs people take besides Indocin i.v. *:
Common side effects people have besides Haematocrit decreased *:
* Approximation only. Some reports may have incomplete information.
Do you take Indocin i.v. and have Haematocrit decreased?Check whether Haematocrit decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Haematocrit decreased and when was it recovered:
Expand to all the drugs that have ingredients of indomethacin sodium:
Alternative drugs to, pros and cons of Indocin i.v.:
- Indocin i.v. (461 reports)
Common Indocin i.v. side effects:
- Drug ineffective: 111 reports
Browse all side effects of Indocin i.v.:a b c d e f g h i j k l m n o p q r s t u v w x y z
Haematocrit decreased treatments and more:
- Haematocrit decreased (31,423 reports)
COVID vaccines that are related to Haematocrit decreased:
- Haematocrit decreased in Moderna COVID Vaccine
- Haematocrit decreased in Pfizer BioNTech Covid Vaccine
- Haematocrit decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Haematocrit decreased:
All the drugs that are associated with Haematocrit decreased:
- Haematocrit decreased (2,869 drugs)
Common conditions associated with Haematocrit decreased:
All the conditions that are associated with Haematocrit decreased:
- Haematocrit decreased (2,196 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on indomethacin sodium (the active ingredients of Indocin i.v.) and Indocin i.v. (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pacerone and Hypotension - a second ago
- Meloxicam and Jejunal Stenosis - 2 seconds ago
- Repatha and Dermal Cyst - 2 seconds ago
- Meloxicam and Levonorgestrel And Ethinyl Estradiol drug interaction - 5 seconds ago
- Pradaxa and Versed drug interaction - 10 seconds ago
- Amlodipine Besylate and Mekinist drug interaction - 21 seconds ago
- Prilosec and Lymphadenitis And Lymphangitis - 21 seconds ago
- Medroxyprogesterone Acetate and Nasacort drug interaction - 22 seconds ago
- Ofirmev and Testicular Swelling - 35 seconds ago
- Xtampza Er and Duragesic drug interaction - 36 seconds ago